Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aurobindo Announces Vaccine Partnership For India

As Dr Reddy's Files For Favipiravir In Canada

Executive Summary

Aurobindo has partnered with US based Covaxx for the first-ever peptide-based COVID-19 vaccine for the Indian market. While Dr Reddy’s has filed for favipiravir in Canada, Cipla has launched its second antigen detection test kit in India. And the Serum Institute of India will be providing Bangladesh with Oxford-AstraZeneca vaccine doses via Beximco

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts